Diagnosing Systemic Amyloidosis Presenting as Carpal Tunnel Syndrome A Risk Nomogram to Guide Biopsy at Time of Carpal Tunnel Release

被引:19
|
作者
Sood, Ravi F. [1 ]
Kamenko, Srdjan [2 ]
McCreary, Eleanor [3 ]
Sather, Bergen K. [3 ]
Schmitt, Michael [2 ]
Peterson, Steven L. [4 ]
Lipira, Angelo B. [2 ,4 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Div Plast & Reconstruct Surg, Boston, MA 02115 USA
[2] Oregon Hlth & Sci Univ, Dept Surg, Div Plast & Reconstruct Surg, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97201 USA
[4] Portland VA Med Ctr, Operat Care Div, Portland, OR USA
来源
关键词
HEART-FAILURE; PREVALENCE;
D O I
10.2106/JBJS.20.02093
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: As carpal tunnel syndrome often precedes other signs of systemic amyloidosis, tenosynovial biopsy at the time of carpal tunnel release may facilitate early diagnosis and treatment. However, evidence-based guidelines for amyloidosis screening during carpal tunnel release have not been established. We sought to develop a predictive model for amyloidosis after carpal tunnel release to inform screening efforts. Methods: We performed a retrospective cohort study of adults without known amyloidosis undergoing at least 1 carpal tunnel release from 2000 to 2019 with use of the national Veterans Health Administration database. After estimating the cumulative incidence of amyloidosis after carpal tunnel release, we identified risk factors, constructed a predictive nomogram based on a multivariable subdistribution-hazard competing-risks model, and performed cross-validation. Results: Among 89,981 patients undergoing at least 1 carpal tunnel release, 310 were subsequently diagnosed with amyloidosis at a median interval of 4.5 years, corresponding to a cumulative incidence of 0.55% (95% confidence interval [CI]: 0.47% to 0.63%) at 10 years. Amyloidosis diagnosis following carpal tunnel release was associated with an increased hazard of heart failure (hazard ratio [HR], 4.68; 95% CI: 4.26 to 5.55) and death (HR, 1.27; 95% CI: 1.07 to 1.51) after adjustment for potential confounders. Age, male sex, Black race, monoclonal gammopathy of undetermined significance or multiple myeloma, rheumatoid arthritis, atrial fibrillation, spinal stenosis, and bilateral carpal tunnel syndrome were independently associated with increased risk of amyloidosis diagnosis and were included in the risk nomogram. Conclusions: Amyloidosis diagnosis after carpal tunnel release is rare but is associated with poor outcomes. We present an amyloidosis-risk nomogram to help guide tenosynovial biopsy at time of carpal tunnel release.
引用
收藏
页码:1284 / 1294
页数:11
相关论文
共 50 条
  • [31] Carpal tunnel syndrome and ATTR-amyloidosis
    Hahn, Katharina
    Urban, Peter
    Meliss, Rolf Ruediger
    Axmann, Hans-Detlef
    Siebert, Frank
    Roecken, Christoph
    HANDCHIRURGIE MIKROCHIRURGIE PLASTISCHE CHIRURGIE, 2018, 50 (05) : 329 - 334
  • [32] CARPAL-TUNNEL AREA AS A RISK FACTOR FOR CARPAL-TUNNEL SYNDROME
    WINN, FJ
    HABES, DJ
    MUSCLE & NERVE, 1990, 13 (03) : 254 - 258
  • [33] Persistent or recurrent carpal tunnel syndrome following prior endoscopic carpal tunnel release
    Forman, DL
    Watson, HK
    Caulfield, KA
    Shenko, J
    Caputo, AE
    Ashmead, D
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 1998, 23A (06): : 1010 - 1014
  • [34] Revision Surgery for Persistent and Recurrent Carpal Tunnel Syndrome and for Failed Carpal Tunnel Release
    Jones, Neil F.
    Ahn, Hee Chang
    Eo, SuRak
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2012, 129 (03) : 683 - 692
  • [35] Effects of diabetes mellitus on the rate of carpal tunnel release in patients with carpal tunnel syndrome
    Jaeyong Shin
    Yong Wook Kim
    Sang Chul Lee
    Seung Nam Yang
    Jee Suk Chang
    Seo Yeon Yoon
    Scientific Reports, 11
  • [36] IS CARPAL-TUNNEL RELEASE, THE STANDARD TREATMENT FOR CARPAL-TUNNEL SYNDROME, OUTDATED
    FURRER, M
    BISCHOF, TP
    HODLER, J
    MEYER, VE
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1994, 124 (22) : 940 - 944
  • [37] The Utility of the Carpal Tunnel Syndrome-6 for Predicting the Outcomes of Carpal Tunnel Release
    Aversano, Francis J.
    Goldfarb, Charles A.
    Gelberman, Richard H.
    Calfee, Ryan P.
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 2022, 47 (10): : 944 - 952
  • [38] Treatment of carpal tunnel syndrome : from ultrasonography to ultrasound guided carpal tunnel release
    Petrover, David
    Richette, Pascal
    JOINT BONE SPINE, 2018, 85 (05) : 545 - 552
  • [39] Surgical outcome of endoscopic carpal tunnel release in 100 patients with carpal tunnel syndrome
    Park, SH
    Cho, BH
    Ryu, KS
    Cho, BM
    Oh, SM
    Park, DS
    MINIMALLY INVASIVE NEUROSURGERY, 2004, 47 (05) : 261 - 265
  • [40] Recurrent carpal tunnel syndrome following endoscopic carpal tunnel release: A preliminary report
    Wheatley, MJ
    Kaul, MP
    ANNALS OF PLASTIC SURGERY, 1997, 39 (05) : 469 - 471